Some of the ARK Invest exchange-traded funds run by ETF star Cathie Wood made a huge purchase on Thursday. The funds bought over 415,000 shares altogether of Teladoc Health Inc. (NYSE: TDOC), as the prices of these ETFs bounced back on Thursday. Note that these funds are up handily in the past year.
Here’s a look at the purchases:
- ARK Fintech Innovation ETF (NYSEARCA: ARKF) bought 40,224 shares.
- ARK Genomic Revolution ETF (NYSEARCA: ARKG) purchased 78,216 shares.
- ARK Innovation ETF (NYSEARCA: ARKK) added 234,681 shares.
- ARK Next Generation Internet ETF (NYSEARCA: ARKW) bought 62,024 shares.
At Thursday’s closing price, this would have valued these purchases at roughly $51.5 million. Even though this is a small fraction of the total holdings, every little bit counts. These funds are up more than 14% in the past 52 weeks, with the exception of the Genomic Revolution ETF, which is actually down 6%.
Check out all of the ARK Invest buys for Thursday:
|ARKG||BNR||BURNING ROCK BIOTECH||46,455|
|ARKQ||BLDE||BLADE AIR MOBILITY||227,784|
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of 247wallst.com.